ArabFinance: The Arab Drug Company (ADCI) posted a net profit before taxes of EGP 129.080 million in the fiscal year (FY) 2020/2021, according to the company’s unaudited financial statements filed to the Egyptian Exchange.

This marked a Year on Year (YoY) rise of 8% when compared to EGP 119.694 million in Q1 2020.

The company’s sales went up to EGP 537.077 million, compared to EGP 520.796 million.

In FY 2021/2022, ADCI is targeting a net profit of EGP 116.3 million and has allocated EGP 129.7 million for the year's investments.

Arab Drug is an Egypt-based company engaged in the pharmaceutical sector. The company focuses on the manufacture, packaging, and distribution of pharmaceutical products as well as chemical solutions for human and veterinary use.